company background image
AN1 logo

Anagenics ASX:AN1 Stock Report

Last Price


Market Cap







25 Feb, 2024


Company Financials

AN1 Stock Overview

Anagenics Limited operates as a health and beauty tech company in Australia, New Zealand, and internationally.

AN1 fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance0/6
Financial Health6/6

Anagenics Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Anagenics
Historical stock prices
Current Share PriceAU$0.015
52 Week HighAU$0.036
52 Week LowAU$0.01
1 Month Change0%
3 Month Change-21.05%
1 Year Change-28.57%
3 Year Change-83.52%
5 Year Change-94.44%
Change since IPO-99.62%

Recent News & Updates

Recent updates

How Much is Cellmid's (ASX:CDY) CEO Getting Paid?

Dec 17
How Much is Cellmid's (ASX:CDY) CEO Getting Paid?

Shareholder Returns

AN1AU Personal ProductsAU Market

Return vs Industry: AN1 underperformed the Australian Personal Products industry which returned -10.9% over the past year.

Return vs Market: AN1 underperformed the Australian Market which returned 4.7% over the past year.

Price Volatility

Is AN1's price volatile compared to industry and market?
AN1 volatility
AN1 Average Weekly Movementn/a
Personal Products Industry Average Movement5.2%
Market Average Movement8.6%
10% most volatile stocks in AU Market16.9%
10% least volatile stocks in AU Market3.3%

Stable Share Price: AN1's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine AN1's volatility change over the past year.

About the Company

2004n/aScott Greasley

Anagenics Limited operates as a health and beauty tech company in Australia, New Zealand, and internationally. It develops and sells FGF5 inhibitor formulations; over-the-counter (OTC), cosmetic antiaging, and longevity targeting products; and imports and distributes international and local skin care and wellbeing products under the Thalgo, Hydro Peptide, Comfort Zone, Priori, and Inika Organic brand names. The company also develops, manufactures, and markets beauty and wellness brands comprising Uspa and evolis.

Anagenics Limited Fundamentals Summary

How do Anagenics's earnings and revenue compare to its market cap?
AN1 fundamental statistics
Market capAU$6.29m
Earnings (TTM)-AU$1.74m
Revenue (TTM)AU$9.11m


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AN1 income statement (TTM)
Cost of RevenueAU$4.70m
Gross ProfitAU$4.41m
Other ExpensesAU$6.15m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date


Earnings per share (EPS)-0.0042
Gross Margin48.41%
Net Profit Margin-19.11%
Debt/Equity Ratio0%

How did AN1 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.